Academic Journal
Q1Endocrine Pathology
About Endocrine Pathology
Endocrine Pathology is a scholarly journal published by Springer. SCImago 2025 lists it in Q1, with an SJR of 3.715 and H-index of 65.
Coverage: 1990-2026. Research categories: Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medicine (miscellaneous) (Q1); Pathology and Forensic Medicine (Q1).
Verified field sources
- Journal Impact Factor: 4.6 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Ozgur Mete MD, FRCPC (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Thyroid Cancer Diagnosis and Treatment; Neuroendocrine Tumor Research Advances; Pituitary Gland Disorders and Treatments; Adrenal and Paraganglionic Tumors; Neuroblastoma Research and Treatments; Cancer, Hypoxia, and Metabolism.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,190.00 USD; 5,090.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Divergent c-MYC Expression Patterns in NET and NEC: Insights from a Multicentre Cohort of 1380 Neuroendocrine Neoplasms
Maxime Schmitt, Katharina Ofner, Detlef Klaus Bartsch, Daniel-Christoph Wagner et al.
2026-12 · DOI: 10.1007/s12022-026-09935-xComprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations
Alessandro Vanoli, Erica Travaglino, Frediano Inzani, Tommaso Orione et al.
2026-12 · DOI: 10.1007/s12022-026-09934-yReal-World-Feasible Immunohistochemistry of ATRX, DAXX, and Menin Identifies a Subgroup of Non-Functioning Pancreatic Neuroendocrine Tumors with low Recurrence Risk to Guide De-Escalating Surveillance
Anna Vera Ditte Verschuur, Wenzel Maximillian Hackeng, Jasvir Jairam, Busra Eldem et al.
2026-12 · DOI: 10.1007/s12022-026-09933-zNeuroendocrine Neoplasms of the Urinary Bladder: Integrating Molecular Advances into a Refined Classification System
Anandi Lobo, Liang Cheng
2026-12 · DOI: 10.1007/s12022-026-09932-0Comprehensive Genomic Analysis in Hereditary Adrenal and Extra-Adrenal Paragangliomas
Helia Purnaghshband, Elif Tuzlali, Kamalika Bhandari Deka, Jeffrey P. Bruce et al.
2026-12 · DOI: 10.1007/s12022-026-09930-2Tumor Necrosis is Associated with an Increased Metastatic and Cardiovascular Risk in Paragangliomas: A Single-Center Series and Meta-Analysis Comparing Necrosis and Cystic Degeneration in Paragangliomas
Anna-Maria Wiejak, Georgiana Constantinescu, Gintare Zygiene, Mercedes Robledo et al.
2026-12 · DOI: 10.1007/s12022-026-09931-1A Cauda Equina Neuroendocrine Tumor with Tyrosine Hydroxylase Expression
Knarik Arkun, Zahra Jalali, Mina G. Safain, Arthur S. Tischler et al.
2026-12 · DOI: 10.1007/s12022-026-09929-9Expansion of Germline Variants in Primary Hyperparathyroidism: Fumarate Hydratase Deficiency as a Cause of Parathyroid Adenomas
Hussam Alkaissi, Elias Chuki, Yi Liu, James Welch et al.
2026-12 · DOI: 10.1007/s12022-026-09928-wIntegrated Pathologic, Genomic, and Transcriptomic Analysis of Renal Neuroendocrine Tumors Reveals Neuroendocrine Transcriptional Programs and Associated Gastrointestinal-Type Epithelium in a Subset of Cases
Eric D. Young, Riya Dua, Stephen Kwak, Pedram Argani et al.
2026-12 · DOI: 10.1007/s12022-026-09925-zCirculating Tumor DNA Analysis in Adrenocortical Carcinoma: A Retrospective Cohort Study
Vania Balderrama-Brondani, Leonardo Marcal, Mohammad Jad Moussa, James P. Long et al.
2026-12 · DOI: 10.1007/s12022-026-09927-xPrevalence and Histologic Features of Multifocal Fibrosing Thyroiditis in the Routine Pathology Practice
Floriana Jessica Di Paola, Maria Vittoria Altavilla, Giulia Calafato, Thais Maloberti et al.
2026-12 · DOI: 10.1007/s12022-026-09926-yAn Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups
Ricardo Blázquez-Encinas, Víctor García-Vioque, Andrea Mafficini, Luca Landoni et al.
2026-12 · DOI: 10.1007/s12022-026-09923-1Distinct ALK Expression Patterns Are Associated with Canonical and Noncanonical STRN::ALK Transcript Architectures in Oncocytic Thyroid Neoplasms
Debora Mota Dias Thomaz, Thais Biude Mendes, Thaise Nayane Ribeiro Carneiro, Luiza Sisdelli et al.
2026-12 · DOI: 10.1007/s12022-026-09924-0Neuroendocrine Tumors of the Gallbladder: A Multicenter Case Series and Systematic Literature Review Indicating Predominantly Non-Aggressive Tumor Behavior and a Common Association with Cholesterol Polyps and Cholesterolosis
Alessandro Vanoli, Yue Xue, Atsuko Kasajima, Rebecca Ruffoni et al.
2026-12 · DOI: 10.1007/s12022-026-09921-3Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
Samuel Backman, Fredrik Axling, Liang Zhang, Johan Botling et al.
2026-12 · DOI: 10.1007/s12022-026-09922-2Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Driven Integration of Ki-67 and Mitotic Count
Giulia Orlando, Valentina Veronesi, Eleonora Duregon, Vanessa Zambelli et al.
2026-12 · DOI: 10.1007/s12022-026-09920-4Molecular Profiling of Digestive Grade 3 Neuroendocrine Tumors Reveals a Shared Molecular Framework with Lower-Grade Tumors, Marked Heterogeneity, and Therapeutic Opportunities
Amedeo Sciarra, Laura Libera, Annarita Destro, Roberta Maragliano et al.
2026-12 · DOI: 10.1007/s12022-026-09918-yImpact of Molecular Testing on Surgical Decision-Making in Indeterminate Thyroid Nodules: A Global Meta-Analysis Across Test Generations
Truong Phan-Xuan Nguyen, Andrey Bychkov, Chan Kwon Jung, Kennichi Kakudo et al.
2026-12 · DOI: 10.1007/s12022-026-09917-zLineage Classification of Pituitary Neuroendocrine Tumors From Whole-Slide Images Using Attention-Guided Graph Representation Learning
Jie Hao, Chen Wang, Jiao Li, Jiang Du et al.
2026-12 · DOI: 10.1007/s12022-026-09919-xClinicopathologic and Molecular Features of Poorly Differentiated Thyroid Carcinomas in Adults ≤ 45 Years of Age
Maria Cristina Riascos, Ellen Marqusee, Sara Ahmadi, Theodora Pappa et al.
2026-12 · DOI: 10.1007/s12022-026-09911-5Reviews
Community Reviews
Version History
September 12, 2026 at 10:45 am
September 12, 2026